Skip to main content
Locke Bryan, MD, Hematology, Augusta, GA

Locke Johnson Bryan MD

Hematologic Oncology


Associate Professor of Medicine

Join to View Full Profile
  • 1411 Laney Walker BlvdAugusta, GA 30912

  • Phone+1 706-721-6744

  • Fax+1 706-721-5566

Dr. Bryan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Locke Bryan is a hematologist in Augusta, GA and is affiliated with Augusta University Medical Center. He received his medical degree from University of Mississippi School of Medicine and has been in practice 9 years. He specializes in hematologic oncology and is experienced in hematology / oncology and stem cell transplant.

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2012 - 2015
  • University of Vermont Medical Center
    University of Vermont Medical CenterResidency, Internal Medicine, 2008 - 2011
  • University of Mississippi School of Medicine
    University of Mississippi School of MedicineClass of 2008

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2015 - 2027
  • IL State Medical License
    IL State Medical License 2012 - 2017
  • VT State Medical License
    VT State Medical License 2008 - 2012
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refracto...
    Locke J. Bryan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classi... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Press Mentions

  • Antibiotic Use May Affect Efficacy of Cancer Immunotherapies
    Antibiotic Use May Affect Efficacy of Cancer ImmunotherapiesMarch 3rd, 2018
  • Antibiotics Influence Cancer Treatment Efficacy
    Antibiotics Influence Cancer Treatment EfficacyMarch 3rd, 2018
  • Scientists Work to Strengthen the Synergy of Chemotherapy and Immunotherapy Against Cancer
    Scientists Work to Strengthen the Synergy of Chemotherapy and Immunotherapy Against CancerApril 17th, 2017

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: